AIM IMMUNOTECH INC. Derivative Liability, Fair Value, Gross Liability
AIM IMMUNOTECH INC. (AIM) had Derivative Liability, Fair Value, Gross Liability of $14.00 thousand as of 2013-12-31, per its 10-K filed 2014-03-14.
Discontinued › Notes
us-gaap:DerivativeFairValueOfDerivativeLiability · last filed 2014-03-14
- 2013-12-31: Derivative Liability, Fair Value, Gross Liability $14.00K.
- 2012-12-31: Derivative Liability, Fair Value, Gross Liability $295.00K.
- 2011-12-31: Derivative Liability, Fair Value, Gross Liability $380.00K.
- 2010-12-31: Derivative Liability, Fair Value, Gross Liability $2.81M.
| Period end | Derivative Liability, Fair Value, Gross Liability |
|---|---|
| 2013-12-31 | $14.00K 10-K · filed 2014-03-14 |
| 2012-12-31 | $295.00K 10-K · filed 2014-03-14 |
| 2011-12-31 | $380.00K 10-K · filed 2013-03-18 |
| 2010-12-31 | $2.81M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |